The success of RNA interference depends on both siRNA sequence design and efficient delivery. Typically 21–23 nucleotides (nt) in length, siRNAs cannot efficiently cross cell membranes on their own and therefore require delivery systems, such as lipid-based transfection reagents, to enter the cytoplasm. If this critical step fails, subsequent experimental results may become unreliable. This article focuses on three frequently asked questions about siRNA transfection: Can serum be added? What should you do if cell viability declines? Can increasing siRNA concentration improve knockdown efficiency?

Pitfall 1: Adding Serum During Lipid–siRNA Complex Formation

Serum contains a large number of proteins, including negatively charged proteins that may interact with cationic lipids and interfere with the formation of lipid–siRNA complexes, potentially reducing transfection efficiency.

Another concern is that serum proteins may interact with lipid-based delivery complexes and contribute to cellular stress or cytotoxicity under certain conditions. This can negatively affect cell health and further compromise transfection performance. Therefore, serum may affect both complex formation and cell viability, depending on the transfection system used.

▎ Practical Guidelines: Requirements Vary by Transfection Reagent

Taking Lipofectamine 2000 as an example, serum-free medium is generally recommended when preparing siRNA–Lipofectamine 2000 complexes. The cell culture medium may contain serum, but antibiotics should be avoided during transfection according to the recommended protocol. Requirements may differ between reagent brands and formulations, so always carefully review the manufacturer's instructions before starting your experiment.

Key takeaway: Prepare complexes in serum-free, antibiotic-free medium; serum may be present during cell culture, while antibiotics should generally be avoided during transfection, subject to the specific reagent protocol.

Pitfall 2: Poor Cell Condition After siRNA Transfection

Poor cell health can compromise both mRNA and protein measurements. The apparent differences observed after gene knockdown may actually result from cytotoxicity rather than specific gene silencing. Consider the following three factors to improve experimental outcomes:

1. Cytotoxicity of Transfection Reagents

Exogenous chemical stimulation may affect cell viability to varying degrees. Potential solutions include optimizing the amount of transfection reagent, adjusting transfection duration (for example, shortening the incubation time between complexes and cells when appropriate), or switching to a transfection reagent with lower cytotoxicity.

2. Cell Health and Culture Conditions

Select healthy cells with a relatively low passage number, maintain an appropriate cell density during transfection, and ensure that cells are in optimal condition before treatment. Although these are fundamental experimental practices, they are also among the most frequently overlooked factors affecting transfection efficiency.

3. Biological Functions of the Target Gene

Some genes are involved in cellular stress responses and other biological processes, making their expression particularly sensitive to external stimuli. When these genes are knocked down, deterioration in cell condition may result from the biological function of the target gene itself rather than transfection reagent toxicity. In such cases, consider adjusting the detection time and moderating the degree of knockdown. Achieving more than 90% knockdown is not always necessary; the goal should be to balance effective gene silencing with acceptable cell viability.

Pitfall 3: Doubling siRNA Concentration to Improve Silencing Efficiency

If satisfactory knockdown efficiency cannot be achieved despite using an established transfection system, the first option should generally be to test alternative siRNA sequences rather than immediately increasing the concentration. If concentration optimization is necessary, it should be performed within a suitable range. A commonly explored optimization range is 10–150 nM, although the appropriate concentration depends on the cell type, reagent, and experimental protocol.

▎ Why Increasing the Dose Indiscriminately Is Not Recommended

High siRNA concentrations may increase nonspecific interactions, off-target effects, and cytotoxicity. As a result, increasing the dose may produce unreliable experimental data rather than improved knockdown efficiency. It is also important to note that the optimal amount of transfection reagent does not necessarily increase linearly with siRNA concentration. Therefore, concentration optimization should follow the manufacturer's recommendations and use a carefully designed concentration gradient rather than simply increasing both components proportionally.

In summary, the recommended troubleshooting sequence is: first verify the transfection conditions (serum, antibiotics, and cell health) → then test alternative siRNA sequences → finally optimize the siRNA concentration within an appropriate range, such as 10–150 nM when supported by the experimental protocol.

Key Takeaways: Quick Reference